Premarket Mover: CTI BioPharma Corp (CTIC) Up 2.91%

Friday, April 22, 2022 06:49 AM | InvestorsObserver Analysts

Mentioned in this article

Premarket Mover: CTI BioPharma Corp (CTIC) Up 2.91%

CTI BioPharma Corp (CTIC) is higher by Friday morning, with the stock adding 2.91% in pre-market trading to 4.95. CTIC's short-term technical score of 94 indicates that the stock has traded more bullishly over the last month than 94% of stocks on the market. In the Biotechnology industry, which ranks 136 out of 146 industries, CTIC ranks higher than 99% of stocks. CTI BioPharma Corp has risen 11.34% over the past month, closing at $5.23 on March 25. During this period of time, the stock fell as low as $4.24 and as high as $5.25. CTIC has an average analyst recommendation of Strong Buy. The company has an average price target of $7.48.

CTIC has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on CTIC!

See Full CTIC Report

CTI BioPharma Corp has a Long-Term Technical rank of 99. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 1% of the market scoring higher. In the Biotechnology industry which is number 133 by this metric, CTIC ranks better than 99% of stocks.

Important Dates for Investors in CTIC:

-CTI BioPharma Corp is set to release earnings on 6/7/2022. Over the last 12 months, the company has reported EPS of $-1.09. -We do not have a set dividend date for CTI BioPharma Corp at this time. Click Here To Get The Full Report on CTI BioPharma Corp (CTIC)